ESC 365 - Neprilysin inhibition.

HFA Premium Access

Neprilysin inhibition.

Session: Novel drugs: how do they work?

Topic: Diuretics

Speaker: Doctor N. Vodovar (Paris, FR)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Nicolas Vodovar

National Institute of Health and Medical Research (INSERM home), Paris (France)

2 presentations

0 follower

4 more presentations in this session

Empaglifozin (SGLT-2 inhibition).

Speaker: Professor N. Marx (Aachen, DE)

Serelaxin

Speaker: Professor J. Teerlink (San Francisco, US)

Potassium binders.

Speaker: Professor B. Pitt (Ann Arbor, US)

Beta-3 Agonists.

Speaker: Professor J. Balligand (Brussels, BE)

Access the full session

Novel drugs: how do they work?

Speakers: Doctor N. Vodovar, Professor N. Marx, Professor J. Teerlink, Professor B. Pitt, Professor J. Balligand

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources